Priothera competitorsClear all

Priothera's top competitors include ChemoCentryx, Tollys, Remegen and GenFleet Therapeutics.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Priothera
Priothera
Priothera is a company that develops receptor modulators intended to improve the lives of patients suffering from hematological malignancies.
ChemoCentryx
ChemoCentryx
ChemoCentryx is a biopharmaceutical company focused on the development and commercialization of medications targeting inflammatory disorders, autoimmune diseases, and cancer.
Tollys
Tollys
Tollys is a biopharmaceutical company focused on innate immunity, particularly on the biology and modulation of the TLR3 receptor.
Remegen
Remegen
Remegen is a company that develops biopharmaceutical products.
GenFleet Therapeutics
GenFleet Therapeutics
GenFleet Therapeutics is a company that develops and researches molecular pharmaceuticals targeting cancer treatments.
Founding Date
Founding Date
2020
Founding Date
1997
Founding Date
2015
Founding Date
2008
Founding Date
2017
Type
Type
Private
Type
Public
Type
Private
Type
Private
Type
Private
Tags
Locations
Locations
Dublin, IE HQ
Locations
San Carlos, US HQ
Locations
Lyon, FR HQ
Locations
Yantai, CN HQ
Locations
CN HQ
Shaoxing Shi, CN
Shaoxing Shi, CN
Employees
Employees
N/A
Employees
13362% increase
Employees
N/A
Employees
1344% increase
Employees
N/A
Alexa Website Rank
Alexa Website Rank
183065
Alexa Website Rank
146268
Alexa Website Rank
N/A
Alexa Website Rank
359388
Alexa Website Rank
233230
Employee Rating
Employee Rating
N/A
Employee Rating
3
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
N/A

Funding

Latest funding round
Latest funding round
$ 35.5m (over 1 year ago)
Latest funding round
N/A
Latest funding round
$ 2.5m (over 1 year ago)
Latest funding round
$ 100m (almost 2 years ago)
Latest funding round
$ 58m (almost 2 years ago)
Total funding raised
Total funding raised
$ 35.5m
Total funding raised
$ 149.5m
Total funding raised
$ 6.8m
Total funding raised
$ 100m
Total funding raised
$ 89m
For sources of this data, please see the company profile

View company profiles

ChemoCentryx
HQ
San Carlos, US
Employees
133

ChemoCentryx is a biopharmaceutical company focused on the development and commercialization of medications targeting inflammatory disorders, autoimmune diseases, and cancer.

View company
Tollys
HQ
Lyon, FR

Tollys is a biopharmaceutical company focused on innate immunity, particularly on the biology and modulation of the TLR3 receptor.

View company
Remegen
HQ
Yantai, CN
Employees
134↑ 4% increase

Remegen is a company that develops biopharmaceutical products.

View company
GenFleet Therapeutics
HQ
CN

GenFleet Therapeutics is a company that develops and researches molecular pharmaceuticals targeting cancer treatments.

View company